Bio-Rad Laboratories (BIO) Financial Analysis & Valuation | Quarter Chart
Bio-Rad Laboratories (BIO)
BIOPrice: $305.56
Fair Value: 🔒
🔒score
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures,... more
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnost... more
Description
Shares
| Market Cap | $8.24B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Norman D. Schwartz |
| IPO Date | 1980-02-27 | CAGR | 0.09% |
| Employees | 7,700 | Website | www.bio-rad.com |
| Div. Yield | — | Payout Ratio | -0.09% |
| Buy Back Yield | 3.18% | Total Yield | 3.18% |
BIO chart loading...
Fundamentals
Technicals
| Enterprise Value | $7.74B | P/E Ratio | -12.73 |
| Forward P/E | 24.61 | PEG Ratio | — |
| P/S Ratio | 3.62 | P/B Ratio | 1.37 |
| P/CF Ratio | 18.77 | P/FCF Ratio | 27.54 |
| EPS | $-24 | EPS Growth 1Y | -11.05% |
| EPS Growth 3Y | -87.95% | EPS Growth 5Y | -120.81% |
| Revenue Growth 1Y | -0.88% | Gross Margin | 0.52% |
| Operating Margin | 0.09% | Profit Margin | -0.26% |
| ROE | -0.1% | ROA | — |
| ROCE | -0.43% | Current Ratio | — |
| Quick Ratio | — | Cash Ratio | — |
| Debt/Equity | 0.03 | Interest Coverage | 4.62 |
| Altman Z Score | — | Piotroski Score | 4 |